Intelligence · Clinical Development
Pipeline search results
Programs matching “asthma” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 226 pipeline programs matching "asthma" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Dupilumab
Regeneron UK Limited
Asthma, Allergic
1 trial -
Epinephrine Inhalation Aerosol, HFA
Amphastar France Pharmaceuticals
Asthma
1 trial -
Experimental: CHF6001 3200 μg
Chiesi Farmaceutici S.p.A.
Uncontrolled Asthma
1 trial -
FF/GSK573719
GlaxoSmithKline
Asthma
1 trial -
FF/GW642444M
GlaxoSmithKline
Asthma
1 trial -
Fluticasone Furoate
GlaxoSmithKline
Asthma
1 trial -
Fluticasone furoate (FF) (100 mcg)
GlaxoSmithKline
Asthma
1 trial -
Fluticasone propionate
GlaxoSmithKline
Asthma
1 trial -
Fp MDPI
Teva Pharma GmbH
Asthma
3 trials -
GSK256066
GlaxoSmithKline
Asthma
1 trial -
INCB 54707-208
Incyte
Treatment of patients with inadequately controlled moderate to severe asthma
1 trial -
Ifetroban Oral Capsule
CUMBERLAND PHARMACEUTICALS INC
Asthma, Aspirin-Induced
1 trial -
J2S-MC-GZMR
Eli Lilly Co.
Asthma
1 trial -
KT-621
Kymera Therapeutics
Eosinophilic Asthma
1 trial -
KT621-AS-202
Kymera Therapeutics
Uncontrolled Moderate to Severe Eosinophilic Asthma
1 trial -
L-citrulline
United Therapeutics Europe Ltd
Post Deployment Related Asthma
1 trial -
LTS17231
Sanofi-aventis Healthcare Pty Ltd
Asthma
1 trial -
Lunsekimig
Sanofi Pasteur
Asthma
1 trial -
Nebulized IVX-0142
Teva Pharma GmbH
Asthma
1 trial -
Placebo
MedImmune
Asthma
1 trial -
Placebo
RIGEL PHARMACEUTICALS INC
Asthma
1 trial -
Placebo
Regeneron UK Limited
Asthma
1 trial -
Placebo for AMG 451, Rocatinlimab
Amgen
Moderate-to-severe Asthma
1 trial -
Placebo for GSK5784283.
GlaxoSmithKline
Asthma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.